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Abstract: 
 
Primary hypertension is not just an adult disorder.  Current US population data on children and 
adolescents demonstrate a prevalence of elevated blood pressure (BP) and hypertension 
combined of over 10%. Recent reports from prospective cohort studies describe an association 
of high BP in childhood with hypertension in young adulthood. Excess adiposity is strongly 
associated with higher BP in childhood and increases risk for hypertension in adulthood. In 
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addition to overweight/obesity, other exposures that raise the risk for high BP include low 
birthweight, dietary sodium, and stress. Using intermediate markers of cardiovascular injury, 
studies on hypertensive children report findings of cardiac hypertrophy, vascular stiffness, and 
early atherosclerotic changes. Impaired cognitive function has also been demonstrated in 
hypertensive children. Recent advances in clinical and translational research support the 
concept that the evolution of primary hypertension begins in childhood.  
 
 
Introduction: 
 
 Reports from clinical and translational studies on blood pressure (BP) and hypertension 
in childhood over the past decade provide new insights on the evolution of primary hypertension 
beginning in the young. Hypertension in children and adolescents has traditionally been defined 
statistically as >95th percentile of the sex, age, and height adjusted normal BP distribution. With 
this definition as a framework, clinical studies that use repeated measurements to confirm a 
diagnosis of hypertension indicate that the prevalence of hypertension in childhood is 
approximately 3.5% and the prevalence of prehypertension is approximately 3.5% with higher 
rates in adolescence.1,2 Many studies report findings that fill gaps in knowledge on childhood 
hypertension, including life-course trends in BP levels and associated risk factors in youth, 
exposures that heighten risk for elevated BP in children and adolescents, and evidence of target 
organ damage associated with childhood hypertension. This review will discuss key areas of 
advancement in knowledge on childhood hypertension. The advancements in clinical and 
translational research provide a platform for further considerations regarding effective strategies 
on management and prevention of childhood hypertension with subsequent reduction of 
premature cardiovascular disease.  
 
Blood Pressure Trends in Childhood:  
 
The childhood obesity epidemic has made a substantial impact on the prevalence of 
elevated blood pressure and hypertension in children and adolescents. Several reports on 
cross-sectional studies confirmed a higher prevalence of hypertension among obese children 
and adolescents.1,3 Studies that compared childhood BP levels from data in serial periods of the 
National Health and Nutrition Surveys (NHANES) also report a progressive increase in 
childhood blood pressure levels. While there are variations according to race, the trend of 
increasing BP level is largely parallel with the trend of increasing adiposity.4-6  The effect of 
excess adiposity on BP can even be detected in early childhood among children age 2 to 4 
years of age.3  In an analysis of data on the relationship of BP with BMI in a cohort of children 
Tu et al.7  demonstrated a stable relationship of BP with BMI up to the 85th percentile of BMI. As 
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BMI exceeds the 85th percentile there is a marked increase in risk for elevated BP in children 
and adolescents. Thus, the risk for elevated BP in children is not limited to obesity (BMI >95th 
percentile) but increases with overweight status (BMI = 85th to 94th percentile).  
 
In adults, the association of hypertension with increased risk for adverse cardiovascular 
and cerebral-vascular outcomes have been clearly established. There are no outcome data on 
the BP level in childhood that increases risk for adverse events later in adulthood. Therefore, 
hypertension in children and adolescents has been defined statistically as >95th percentile.8  
The database from which the normative childhood BP distributions are determined and 
delineate the BP levels at the 95th percentile in boys and girls according to age and height 
percentile, does include overweight and obese children. Rosner et al.9 conducted a re-analysis 
of this database, but included only children and adolescents with normal BMI (<85th percentile). 
The results demonstrated that the sex, age, and height adjusted BP levels at the 95th percentile 
were lower than BP levels in the existing tables of the Fourth Report on evaluation and 
management of hypertension in childhood published in 2004.8  These results also became a key 
consideration in the subsequent update of the clinical guidelines on pediatric hypertension. 
 
The childhood obesity epidemic with parallel increase in prevalence of elevated BP 
predict heightened risk for premature cardiovascular disease in adulthood. New insights 
regarding this concern have been gained from prospective studies on cohorts that enrolled 
participants in childhood and conducted periodic re-examinations into young adulthood.  The 
International Childhood Cardiovascular Cohort Consortium is comprised of four prospective 
cohort studies that together include data on >6,000 individuals, collected prospectively from 
childhood to young adulthood. An analysis of data on BMI status from childhood to adulthood 
was conducted to determine the risk of excess adiposity for hypertension and other metabolic 
parameters in adulthood. Compared to individuals with normal BMI status in both childhood and 
as adults, individuals with consistently high BMI in both childhood and adulthood had an 
increased risk of hypertension with relative risk (RR) 2.7 [2.2-3.3]. With additional metabolic risk 
factors in childhood the risk increased. However, individuals with high BMI in childhood but 
normal BMI in adulthood had a RR similar to those with consistently normal BMI in both 
childhood and adulthood.10  A similar analysis of combined data was conducted by this 
consortium to determine the effects of child and adult elevated BP on subclinical atherosclerosis 
in adulthood, ascertained by carotid intimal thickness (cIMT) in 4210 participants.  Elevated BP 
in childhood was defined as systolic or diastolic BP >90th percentile and in adulthood as 
>120/80 mm Hg or self-reported anti-hypertension medication use. Individuals with persistently 
child and adult elevated BP and individuals with normal childhood BP, but elevated adult BP 
had increased risk of high cIMT; RR 1.82 [1.47-2.38] and 1.57 [1.22-2.02] respectively 
compared to individuals with normal child and adult BP. Individuals with elevated BP as 
children, but not as adults, did not have increased risk; 1.24 [0.92-1.67].11 Two other recent 
reports, on prospective cohort studies, describe similar results on the heightened risk for 
vascular stiffness among individuals with persistent elevated BP from childhood to adulthood. 
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Also, among individuals with elevated BP in childhood but normal BP in adulthood, the risk for 
vascular stiffness is similar to those with consistently normal BP from childhood to 
adulthood.12,13   
      The findings from life-course studies spanning childhood to young adulthood 
demonstrate the heightened risk of obesity and elevated BP in childhood on young adult 
hypertension and provide evidence of atherosclerotic injury in early adulthood. A similar life-
course study by Ferreira et al spanning age 13 to 36 years detected greater carotid artery 
stiffness in adulthood among those with higher BP and greater central adiposity from 
adolescence to adulthood. It is notable that the effects of BP and central adiposity on carotid 
stiffness were statistically independent of each other. The striking finding, of these prospective 
cohort studies from childhood to young adulthood, is that when childhood obesity and elevated 
BP are reversed by adulthood the risk for abnormal measures of vascular injury are similar to 
individuals with normal BMI status. It is also notable that the effects of high BP and obesity 
appear to be statistically independent of each other.12  
  Two recent publications provide additional clarity on the progression of BP levels in 
childhood to elevated BP and hypertension in adulthood.  Theodore et al.14 conducted an 
analysis of prospective data from the Dunedin Multidisciplinary Health and Development Study 
to identify subgroups with different risks of developing hypertension in young adulthood.  BP 
and related risk factors were measured at age 7 years with periodic repeated measurements up 
to age 38 years in a cohort that included 975 individuals. Using group-based trajectory 
modeling, four distinct trajectory groups were identified based on BP classification at age 38 
years; normal (21.8%), high-normal (43.3%), prehypertension (31.6%), and hypertensive 
(4.2%). The trajectory curves for systolic BP provide a distinct progression in BP level from age 
7 years to age 38 years in each BP category, with clear separation of the BP groups by early 
adolescence. Most notable is that systolic BP levels in the normal and high normal BP groups 
remain under 120 mm Hg until the final measurement at age 38 years. Antecedent risk factors, 
detected by age 7 years, increased the risk for later hypertension and included family history of 
hypertension, male sex, being first born, and low birth weight. Modifiable risk factors including 
higher BMI and cigarette smoking resulted in increasing BP across trajectories in the higher BP 
groups.  In a similar study, Hao et al.15 analyzed existing data in the Longitudinal Georgia Stress 
and Heart Study, a cohort of 683 participants examined prospectively from childhood to young 
adulthood. Data on left ventricular mass index (LVMI) and cIMT were available for analysis on 
546 participants. These investigators identified three systolic BP trajectory groups designated as 
high-increasing, moderate-increasing, and low-increasing groups. By age 18 years, the high-
increasing BP group had significantly greater LVMI and cIMT compared to the low-increasing 
group. Again, it is notable by the trajectory curves that systolic BP exceeded 120 mm Hg by age 
14 years in the high-increasing group. Together these studies advance knowledge on the 
origins of hypertension beginning in the young. The findings also provide insights on potential 
cardiovascular health benefits of interventions on modifiable risk factors, including preventing or 
correcting childhood obesity and other related health behaviors.   
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Ambulatory Blood Pressure Monitoring (ABPM): 
 
 BP measurement in population studies, such as NHANES, and the cohort studies 
described above are obtained according to a standard and rigorous measurement protocol to 
ensure measurement quality. BP measurements obtained in children during a clinic setting are 
known to be less reliable due to variations in the conditions of measurement, inaccurate 
auscultation technique, and use of various automated BP instruments. Recent applications of 
24-hour ABPM in children have been an advancement in confirming the clinical diagnosis of 
hypertension in children and adolescents. Reference normative ABPM data in childhood are 
now available and criteria for ambulatory hypertension have been described.16  ABPM was 
originally used to confirm hypertension or identify white coat hypertension, a condition in which 
clinic BP measurements are elevated but BP measurements outside a clinic setting are normal. 
ABPM has also become a powerful tool in clinical research in children as well as adolescents. 
Masked hypertension, a condition wherein clinic BP measurements are considered normal but 
BP levels outside the clinic are elevated, has been recognized in adults and is considered to be 
a significant risk condition for adverse cardiovascular outcomes. The first to identify masked 
hypertension in childhood were Lurbe et al.17  who performed 24-hour ABPM on 592 children 
and adolescents age 6 to 18 years of age.  In this cohort of healthy children normal office BP 
and ambulatory hypertension, consistent with masked hypertension, was detected in 45 (7.6%) 
children. In a subsequent study these investigators found a progression from masked 
hypertension to sustained hypertension over a three-year period of 7% per year, that was 
largely among boys.18  Subsequent reports describe masked hypertension in children with other 
clinical conditions including chronic kidney disease, diabetes type 1 and type 2, solid organ 
transplant, and sickle cell disease.19  
ABPM has also been recently utilized to develop novel insights on mechanistic pathways 
of primary hypertension in childhood.  Based on observations of BP variability in children, Litwin 
et al.20 investigated cardiovascular rhythms by Fourier analysis of 24-hour ABPM data in a 
sample of 129 hypertensive and 140 normotensive control children. They detected an increased 
prevalence of 12 hour rhythms in the hypertensives compared to controls (67% vs 51%, 
P<0.0001), and the amplitudes of the 24, 8, and 6 hour rhythms were reduced in hypertensive 
vs control children (P<0.05), findings consistent with altered BP rhythmicity in primary 
hypertension onset in youth and indicative of alterations in sympathetic nervous system activity. 
In a subsequent study by these investigators obtained data on 24-hour ABPM, left ventricular 
mass(LVM), CIMT, and visceral and subcutaneous adipose tissue mass (quantified by MRI) in 
50 hypertensive boys before and following 12 months of antihypertensive treatment to lower BP. 
Following treatment, 68% of the hypertensive boys were normotensive. LVM and cIMT were 
decreased in 60% and 62% of the boys. There were no differences in changes in BP or heart 
rate rhythms between patients who did or did not achieve normal BP or regression of LVM and 
cIMT. However, there were rhythmicity findings related to visceral fat. A decrease in visceral fat 
correlated with the decrease in 24-hour mean arterial pressure and heart rate acrophases 
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(p<0.05). These results indicate that abnormal cardiovascular rhythmicity in hypertensive youth 
persists despite reduction in BP, suggesting that abnormal rhythmicity could be a primary 
abnormality or that the abnormal rhythmicity could be mediated by visceral fat.21   
Overall, ABPM can be a clinical research tool to unravel the linkage between elevated 
BP, obesity, and sympathetic nervous system activity. ABPM has also become a diagnostic 
procedure to confirm hypertension and BP status. Guidelines for clinical application and use of 
ABPM and diagnostic criteria for hypertension, elevated BP, white coat hypertension, and 
masked hypertension have been recently updated.22  Based on the prevailing evidence, ABPM 
is now recommended to confirm the diagnosis of hypertension in children and adolescents in 
the 2017 clinical practice guidelines on hypertension in children and adolescents.23 
 
 
Risk Factors for High BP in Childhood: 
 
 Low birth weight is a recognized risk factor for development of hypertension later in life. 
The low birth weight hypothesis is based on the theory of fetal programing wherein adverse 
intrauterine exposures set the stage for chronic disease in adulthood. Epidemiological studies 
have identified a relationship of low birth weight with adverse outcomes in later adulthood; and 
experimental research has developed plausible mechanistic pathways to chronic hypertension. 
However, evidence of a direct link of low birthweight to elevated BP in childhood remains 
limited. Recent epidemiologic studies have reported an association of low birth weight with 
higher BP in offspring of maternal hypertensive disorders,24 with accelerated growth periods in 
early childhood and subsequent elevated BP,25 and in offspring of maternal and paternal 
obesity.26  Another study examined a sample of healthy young children, mean age 8 years, who 
by history had low birth weight, to determine if low birth is associated with alterations in 
cardiovascular rhythmicity computed from 24-hour ABPM data. Compared to age and sex 
matched children with normal birth weight, the average daytime and night time BP levels were 
higher in the children with low birth weight. BP rhythmicity was different between the groups 
indicating heightened sympathetic nervous system activity in the children with low birth weight.27  
 
Prospective studies to address the risks of low birth weight on offspring of normal 
pregnancies that begin in the newborn period are limited.  In a small, but rigorous, prospective 
study by Lurbe et al.28 a sample of healthy full-term newborn offspring of normal pregnancies 
were stratified by birth weight as small (SGA), appropriate, or large for gestational age. BP at 2 
days was positively associated with birth weight. Subsequent BP and growth parameters were 
measured at 6 months, 2 years, and 5 years. After 6 months, current weight and weight gain 
were positively associated with birth weight; and birth weight was not associated with BP level. 
At the 5-year examination, a blood sample was obtained for metabolic parameters, including 
glucose, insulin, and lipids; and the birth weight groups were further stratified according to 
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current weight (heavy, middle, small). Fasting insulin levels were higher in all infants who 
became heavy at age 5 years and was highest among those who were SGA. Moreover, insulin 
resistance estimated by the homeostatic model assessment index, was higher in the entire SGA 
group.  In addition to relative insulin resistance, the SGA group also had lower high-density 
lipoprotein-cholesterol and higher uric acid levels compared to the other birth weight groups. 
These findings suggest that some intrauterine exposure related to lower birth weight may have 
induced metabolic programing for relative insulin resistance that is sustained, at least in early 
childhood, regardless of later weight status. It is plausible that high BP could emerge later as a 
consequence of insulin resistance. 
Other exposures in the extra-uterine environment can have an impact on BP levels. The 
strong association of high dietary sodium intake on BP levels in adults is well known.  Data to 
support the association of sodium intake with BP levels in childhood have been less clear.  An 
earlier report on a meta-analysis of 13 randomized clinical trials in healthy adolescents on the 
effects of a reduction in dietary salt intake detected a small but statistically significant effect in 
lowering BP.29  Recent estimates of dietary salt intake among children and adolescents in the 
UK30  and in the US31 are high and exceed recommended levels. Based on NHANES data, the 
average sodium intake of children age 6 to 10 years is 2,903 mg/d.  Average sodium intake is 
3,194 mg/d for ages 11 to 14 years, and for adolescents at 14 to 18 years the average sodium 
intake is 3,672 mg/d.  There is now childhood population data that demonstrate a significant 
association of sodium intake on BP level and prevalence of elevated BP especially among 
overweight and obese children and adolescents. An analysis of NHANES 2003 to 2008 data 
was conducted by Yang et al.32 to determine if there is an association of dietary salt intake with 
BP.  In a data sample that included 6235 children age 3 to 18 years, 37% had a BMI >85th 
percentile indicating overweight or obese status. Based on analysis of multiple 24-hour dietary 
recall measures, the estimated average intake of sodium was 3,890 mg/d.  For the entire 
sample of children, each 1000 mg/d of sodium intake was associated with approximately 1.0 
mm Hg increase in systolic BP.  Among only overweight/obese children, each 1000 mg/d of 
sodium intake was associated with an increase in systolic BP of 1.5 mm Hg. All children were 
stratified according to quartiles of sodium intake and the prevalence of prehypertension and 
hypertension (high BP) combined in each quartile was determined. For the entire sample the 
adjusted odds ratio for high BP in the high sodium intake group compared to the low sodium 
intake was 2.0 (95% confidence interval; 0.95-4.1, p=0.062). For the overweight/obese 
participants the adjusted odds ratio for high BP in the high sodium intake group compared to low 
sodium intake increased to 3.5 (95% confidence interval; 1.2-9.2, p=0.013). These findings were 
advanced in a subsequent study by Rosner et al.6  An analysis of NHANES data from 1988 to 
2008 was conducted to investigate trends in childhood BP levels. A progressive and significant 
increase in childhood BP levels were demonstrated over this time period. An analysis of risk 
factors associated with development of high BP determined that BMI, waist circumference, and 
dietary sodium intake were each independently associated with the combined prevalence of 
prehypertension and hypertension. The results of these two studies on NHANES data provide 
evidence of BP sensitivity to sodium intake among children with excess adiposity, beginning 
with overweight status. 
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 Stress, especially mental stress, is known to increase BP levels in children as well as 
adults. In several studies, Harshfield and colleagues have investigated the role of mental stress 
on the concept of pressure-induced natriuresis in youth. These investigators established a 
rigorous protocol that includes three days of a controlled diet with moderate sodium intake 
(4000 mg Na) that is followed by a 5-hour procedure of 2-hour pretest rest (baseline), 1 hour 
competative video game with monetary reward incentive (stress), and 2-hour post-test rest 
(recovery). Timed collections of urine samples are collected each hour to compute sodium 
excretion. These studies in healthy adolescents have identified an increase in sodium excretion 
that parallels the increase in BP during the stress period; They also identified some individuals 
who have a decrease in sodium excretion during the stress period despite a comparable or 
even greater increase in BP levels. In designating the different responses as “Excreter” for the 
increase in stress-induced pressure natriuresis or “Retainer” for the decrease in stress-induced 
pressure natriuresis, the investigators found a greater prevalence of Retainers among African 
Americans compared to Caucasians and associations with adiposity.33-35 These investigators 
recently added another dimension to their investigations on impaired stress-induced pressure 
natriuresis. Based on findings from laboratory experiments, urinary endothelin-1 (ET-1) 
excretion was added to their study protocol. Within the vascular system, ET-1 is a potent 
vasoconstrictor via the ETA receptor.  However, within the kidney ET-1 has diuretic and 
natriuretic effects presumably via ETB receptors. In a recent publication, the investigators 
reported an increase in urinary ET-1 concentration from baseline to the stress period in the 
Excreters. Urinary ET-1 concentrations were different in the Retainers with higher levels at 
baseline but during stress the urinary ET1 levels decreased and remained lower during 
recovery.36  These novel findings in youth indicate that renal ET-1 may contribute to impaired 
stress-induced pressure natriuresis in the young. In another related study from this group, the 
investigators sought to determine if there was an association of real-life stress in childhood with 
measures of cardiovascular injury and ET-1. In their longitudinal cohort study with multiple 
cardiovascular measures, including BP, PWV, and calculated peripheral resistance index, were 
obtained during childhood and young adulthood. At the most recent examination in later 
adolescence and young adulthood 221 healthy participants completed a standard questionnaire 
on adverse childhood experiences. The questionnaire was designed to capture stressful 
childhood experiences such as abuse, neglect, and various types of household dysfunction. The 
participants’ responses were classified as none, mild (1 adverse experience), or 
moderate/severe (2 or more adverse experiences). Compared to participants with no adverse 
experiences in childhood, those with moderate/severe adverse childhood experiences had 
higher diastolic BP, higher peripheral resistance, and higher PWV. There was also a difference 
in Plasma ET-1 levels that were related to adverse childhood experiences.  Compared to those 
with no adverse experiences, plasma ET-1 was 18% higher in those who reported one adverse 
experience, and ET-1 was 24% higher among those who reported 2 or more adverse 
experience in childhood.37  These reports advance clinical insights on the mechanisms of acute 
stress in childhood, that can be replicated in a laboratory, and also on the cardiovascular 
consequences of chronic stressful experiences in childhood.  
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 Based on early evidence that an increase in cardiac mass could be found in 
hypertensive children, the National Heart Lung and Blood Institute sponsored Fourth Report on 
High BP in children and adolescents recommended including an evaluation for TOD in children 
with confirmed hypertension, including echocardiographic assessment of left ventricular mass.8  
Since publication of that 2004 report, several publications, based on cross-sectional studies, 
have confirmed the frequent presence of LVH among hypertensive children and adolescents.38-
40  Subsequent studies reported evidence of LVH in adolescents with prehypertension. In a 
cohort that included type 2 diabetics, Urbina et al.41 reported greater LVMI among 
prehypertensive adolescents compared to normotensive adolescents. In another study on a 
cohort of African American adolescents, the effects of prehypertension and obesity on left 
ventricular mass were examined. The investigators reported significantly higher LVMI among 
prehypertensive adolescents compared to normotensive adolescents.  LVMI was highest, with 
significantly more LVH, among those with both prehypertension and obesity. In this study, the 
associations of prehypertension and obesity with LVMI were found to be independent and 
additive.42  The common finding of hypertension among obese adolescents has led to further 
considerations about the effect obesity on cardiac mass that can be found even in normotensive 
obese children and adolescents.43,44  Moreover, since publication of the Fourth Report in 2004, 
several new approaches to diagnosing and defining LVH in children and adolescents have been 
published, which has led to uncertainty on the most accurate method to assess cardiac mass 
and define LVH.45  Due to this uncertainty, the 2017 guidelines on hypertension in children and 
adolescents have modified recommendations on determination of LVH in hypertensive children 
and adolescents.23  A novel advancement is the development of techniques to quantify systolic 
and diastolic function using 3-dimensional speckle tracking echocardiography. Information on 
cardiac function, in addition to cardiac structure, could provide additional insights on TOD in 
hypertensive children and adolescents. Recent reports that applied 3-dimensional speckle 
tracking technique to quantify systolic and diastolic function describe alterations in hypertensive 
children.46,47  Using this advanced echocardiographic procedure, Navarini et al.47 examined 26 
hypertensive and 37 children (mean age 14.3 years) and 37 normotensive children (mean age 
11.4 years). Myocardial deformation was reduced in hypertensive children compared to 
controls, with significantly lower global longitudinal strain, global circumferential strain, global 
radial strain, and global 3-dimensial strain. These findings provide evidence of impaired left 
ventricular relaxation and longitudinal systolic function in hypertensive children consistent with 
impaired diastolic and systolic function. The study is limited somewhat by a normotensive 
control group that was somewhat younger with lower BMI than the hypertensives. These 
findings need to be replicated in prospective studies and applied with repeat assessments 
following interventions to lower BP. However, the capacity to pair structural and functional 
cardiac measures are likely to improve assessment of cardiac TOD in hypertensive children. 
    Cardiovascular changes in hypertensive children are not limited to the heart.  
Increased arterial stiffness, a vascular change generally associated with aging, has been 
detected in pediatric patients with high BP, as well as other conditions associated with 
cardiovascular disease including obesity, diabetes and dyslipidemia.39,48  Compared to 
normotensive children, measurements of cIMT, a surrogate marker for preclinical 
Target Organ Damage (TOD) in Hypertensive Children: 
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atherosclerosis in adults, are reported to be higher in children with elevated BP, as well as in 
children with diabetes and familial hypercholesterolemia.49,50  BP associated vascular changes 
have also been detected in adolescents with prehypertension.  As reported by Urbina et al.,41 in 
a cohort of adolescents, PWV and cIMT were significantly higher among hypertensives 
compared to normotensive participants, and these vascular measures were also significantly 
higher in prehypertensive participants compared to normotensives. These findings indicate that 
the risk for cardiovascular TOD in adolescence may increase at BP levels below the current 
definition of hypertension in childhood.  
 Adults with hypertension are at heightened risk of developing impaired cognitive function 
that can progress to dementia.  Recent reports by Lande et al.,51,52 describe cognitive function 
alterations in hypertensive adolescents. The investigators examined 75 untreated children with 
primary hypertension, age 10-19 years of age, and 75 frequency matched normotensive control 
children. BP status was confirmed by ABPM in all participants, who then completed a panel of 
tests to ascertain cognitive function, including tests of general intelligence, attention, memory, 
executive function, and processing speed. There was no difference in hypertension and control 
groups in age, sex, maternal education, income, race, ethnicity, obesity, anxiety, or depression. 
The hypertensive group demonstrated significantly lower performance on neurocognitive test 
scores compared with normotensive controls on measures of memory, attention, and executive 
function. In a subsequent study, the investigators sought to determine if there would be an 
improvement in cognitive function test performance in the hypertensive children following 
antihypertensive therapy. Following 12 months of standard recommended antihypertensive 
treatment, BP, ABPM, and cognitive function testing was repeated in both hypertensives (N=55) 
and controls N=66). Mean BP levels in the hypertensive group were lower following the 12-
month treatment period. The hypertensives improved their cognitive test scores, but the 
normotensives also improved their scores. With further analyses, it was determined that the 
hypertensive adolescents who achieved BP control improved their cognitive test scores 
comparable to the normotensive controls; whereas the hypertensives who did not improve BP 
control had no improvement in cognitive function scores. These findings provide evidence that 
the brain is a site of TOD even in hypertensive youth, and indicate that the changes in brain 
function are potentially reversible with BP reduction. 
 
Guidelines on Evaluation and Management of Childhood Hypertension: 
 
 Based upon new findings on high BP in children and adolescents, some of which has 
been discussed above, the US guidelines on evaluation and management of hypertension in 
children and adolescents were recently updated.23  Although, primary care clinicians are now 
measuring BP in children, it has been apparent that elevated BP levels in children are frequently 
not recognized, and BP measurement techniques are variable. The new guidelines provide 
details on correct BP measurement in children and include a simplified BP table for screening. 
Due to the established association of childhood overweight and obesity with abnormal BP, the 
BP tables, designating the 90th and 95th percentiles for BP by sex, age, and height are now 
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based on normal weight children only. The definition of hypertension remains the same for 
children <13 years of age as BP >95th percentile, and the definition of elevated BP (previously 
designated prehypertension) is BP >90th percentile but <95th percentile. However, for children 
>13 years of age, hypertension is defined numerically as >130/80 mm Hg; and elevated BP is 
defined as >120/<80 to <130/80 mm Hg.  The BP levels that define hypertension and elevated 
BP are concurrent with the updated hypertension guidelines for adults.53  Additional 
modifications were added including a recommendation of ABPM to confirm hypertension and 
identify white coat or masked hypertension. An update of the European guidelines on childhood 
hypertension management, published in 2016, preceded the US guideline update, and the two 
guidelines are similar in scope.54 The European guideline use the same definition of 
hypertension (and abnormal BP) in children <16 years of age and continue to use the BP tables 
from the Fourth Report.8 These guidelines also adapted the adult definition of hypertension for 
adolescents. At age >16 hypertension is defined as BP >140/90 mm Hg, and “high normal” is 
defined as 130/80 to 139/89 mm Hg. The main difference in these two recent guidelines is that 
adolescent age and BP levels that define hypertension are higher in the European guidelines. 
The European guidelines also provide additional detail on newer non-invasive techniques to 
characterize cardiovascular phenotypes associated with abnormal BP and other risk factors. 
The history of clinical guidelines on management of hypertension in children, as well as adults, 
is that future updates will be forthcoming as new evidence emerges to support optimal 
management of abnormal BP in youth. 
 
Summary: 
 
 Publications in the past decade provide new insights on the early phase of hypertension 
beginning in childhood. Prospective cohort studies with repeated examinations of BP and 
related risk factors from childhood to early adulthood describe BP trajectories that link higher BP 
in childhood with hypertension and elevated BP in adulthood. These studies identify evidence of 
TOD in adulthood that are associated with higher BP in childhood. In addition to low birth 
weight, a marker of likely adverse intrauterine exposure, other childhood exposures including 
excess adiposity, high dietary salt, and even chronic stress contribute to higher BP in childhood. 
Emerging findings on BP associated TOD in children with hypertension indicate that the high 
blood pressure can be more than increased risk for subsequent cardiovascular disease, but 
indicate that hypertension related cardiovascular injury is already underway. A current research 
challenge is to determine the BP level or BP percentile in childhood that increases risk for TOD. 
More optimistic are the findings that when childhood risk factors of elevated BP and obesity are 
normalized by adulthood the risk for cardiovascular disease becomes comparable to 
normotensive adults. Overall, the recent advances in pediatric hypertension demonstrate that 
the early phase of primary hypertension can begin in childhood. 
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